In a retrospective multicenter study of 138 NAFLD patients pemafibrate improved the levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT), fibrotic biomarkers and FAST score (FibroScan-AST), a novel index of steatohepatitis [152]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.